126 related articles for article (PubMed ID: 6420136)
21. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
22. Multifocal contact dermatitis to nitroderm TTS 5 with extensive postinflammatory hypermelanosis.
Harari Z; Sommer I; Knobel B
Dermatologica; 1987; 174(5):249-52. PubMed ID: 2953633
[TBL] [Abstract][Full Text] [Related]
23. Allergic reactions to local glyceryl trinitrate administration.
Kounis NG; Zavras GM; Papadaki PJ; Soufras GD; Poulos EA; Goudevenos J; Alangoussis A; Antonakopoulos K; Frangides C; Peristeropoulou SA; Koutsojannis C
Br J Clin Pract; 1996 Dec; 50(8):437-9. PubMed ID: 9039714
[TBL] [Abstract][Full Text] [Related]
24. Allergic contact dermatitis secondary to topical nitroglycerin.
Sausker WF; Frederick FD
JAMA; 1978 Apr; 239(17):1743-4. PubMed ID: 416235
[No Abstract] [Full Text] [Related]
25. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
Chien YW
Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
[TBL] [Abstract][Full Text] [Related]
26. A review of contact dermatitis associated with transdermal therapeutic systems.
Holdiness MR
Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
[TBL] [Abstract][Full Text] [Related]
27. Severe contact dermatitis due to nitroglycerin patches.
Fischer RG; Tyler M
South Med J; 1985 Dec; 78(12):1523-4. PubMed ID: 3934763
[TBL] [Abstract][Full Text] [Related]
28. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
Kapoor AS; Dang NS; Reynolds RD
Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.
Scardi S; Camerini F; Pandullo C; Pollavini G
Int J Cardiol; 1991 Aug; 32(2):241-8. PubMed ID: 1917174
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin (author's transl)].
Garnier B; Imhof P; Spinelli F; Jost H
Schweiz Rundsch Med Prax; 1982 Mar; 71(12):511-6. PubMed ID: 6806799
[No Abstract] [Full Text] [Related]
31. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
32. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
Luke R; Sharpe N; Coxon R
J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
[TBL] [Abstract][Full Text] [Related]
33. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
DeMots H; Glasser SP
J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
35. Allergic contact dermatitis from nitroglycerin and estradiol transdermal therapeutic systems.
Torres V; Lopes JC; Leite L
Contact Dermatitis; 1992 Jan; 26(1):53-4. PubMed ID: 1534736
[No Abstract] [Full Text] [Related]
36. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
Whalley DW; Hellestrand KJ
Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727
[TBL] [Abstract][Full Text] [Related]
37. Adverse dermatologic reactions to transdermal drug delivery systems.
Hogan DJ; Maibach HI
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):811-4. PubMed ID: 2112162
[TBL] [Abstract][Full Text] [Related]
38. Clinical experience with a transdermal nitroglycerin system.
Mahapatra RK; Mahapatra D; Yaden S
Angiology; 1987 Apr; 38(4):277-86. PubMed ID: 3107441
[TBL] [Abstract][Full Text] [Related]
39. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
Savonitto S; Motolese M; Agabiti-Rosei E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
[TBL] [Abstract][Full Text] [Related]
40. Application of asymmetric TPX membranes to transdermal delivery of nitroglycerin.
Wang DM; Lin FC; Chen LY; Lai JY
J Control Release; 1998 Jan; 50(1-3):187-95. PubMed ID: 9685885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
